Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panel.
Hino M, Matsuda K, Miyanaga A, Kuribayasi H, Mizutani H, Noro R, Minegishi Y, Okano T, Seike M, Kawakami A, Yoshimura A, Ogawa N, Uesaka H, Kudoh S, Gemma A.
Hino M, et al.
Exp Ther Med. 2010 Jan;1(1):41-45. doi: 10.3892/etm_00000007. Epub 2010 Jan 1.
Exp Ther Med. 2010.
PMID: 23136590
Free PMC article.